Current status of health technology reassessment of non-drug technologies: survey and key informant interviews

<p>Abstract</p> <p>Background</p> <p>Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology...

Full description

Bibliographic Details
Main Authors: Leggett Laura E, Mackean Gail, Noseworthy Tom W, Sutherland Lloyd, Clement Fiona
Format: Article
Language:English
Published: BMC 2012-12-01
Series:Health Research Policy and Systems
Online Access:http://www.health-policy-systems.com/content/10/1/38
id doaj-6f44272effa745eb9c66a17952330459
record_format Article
spelling doaj-6f44272effa745eb9c66a179523304592020-11-24T21:42:01ZengBMCHealth Research Policy and Systems1478-45052012-12-011013810.1186/1478-4505-10-38Current status of health technology reassessment of non-drug technologies: survey and key informant interviewsLeggett Laura EMackean GailNoseworthy Tom WSutherland LloydClement Fiona<p>Abstract</p> <p>Background</p> <p>Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology in comparison to its alternatives. Little is known about current international HTR practices. The objective of this research was to summarize experience-based information gathered from international experts on the development, initiation and implementation of a HTR program.</p> <p>Methods</p> <p>A mixed methods approach, using a survey and in-depth interviews, was adopted. The survey covered 8 concepts: prioritization/identification of potentially obsolete technologies; program development; implementation; mitigation; program championing; stakeholder engagement; monitoring; and reinvestment. Members of Health Technology Assessment International (HTAi) and the International Network of Agencies for Health Technology Assessment (INAHTA) formed the sampling frame. Participation was solicited via email and the survey was administered online using SurveyMonkey. Survey results were analyzed using descriptive statistics. To gather more in-depth knowledge, semi-structured interviews were conducted among organizations with active HTR programs. Interview questions were developed using the same 8 concepts. The hour-long interviews were recorded, transcribed and analyzed using constant comparative analysis.</p> <p>Results</p> <p>Ninety-five individuals responded to the survey: 49 were not discussing HTR, 21 were beginning to discuss HTR, nine were imminently developing a program, and 16 participants had programs and were completing reassessments. The survey results revealed that methods vary widely and that although HTR is a powerful tool, it is currently not being used to its full potential. Of the 16 with active programs, nine agreed to participate in follow-up interviews. Interview participants identified early and extensive stakeholder engagement as the most important factors for success. A lack of top-down support and financial and human resources are inhibiting program development.</p> <p>Discussion</p> <p>HTR is in its infancy. Although HTRs are being conducted, there are no standardized approaches. However, much can be learned from current international work. Future work should focus on developing a comprehensive methodology, reporting the processes of reassessments and sharing successes and challenges in a common platform.</p> http://www.health-policy-systems.com/content/10/1/38
collection DOAJ
language English
format Article
sources DOAJ
author Leggett Laura E
Mackean Gail
Noseworthy Tom W
Sutherland Lloyd
Clement Fiona
spellingShingle Leggett Laura E
Mackean Gail
Noseworthy Tom W
Sutherland Lloyd
Clement Fiona
Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
Health Research Policy and Systems
author_facet Leggett Laura E
Mackean Gail
Noseworthy Tom W
Sutherland Lloyd
Clement Fiona
author_sort Leggett Laura E
title Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_short Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_full Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_fullStr Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_full_unstemmed Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_sort current status of health technology reassessment of non-drug technologies: survey and key informant interviews
publisher BMC
series Health Research Policy and Systems
issn 1478-4505
publishDate 2012-12-01
description <p>Abstract</p> <p>Background</p> <p>Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology in comparison to its alternatives. Little is known about current international HTR practices. The objective of this research was to summarize experience-based information gathered from international experts on the development, initiation and implementation of a HTR program.</p> <p>Methods</p> <p>A mixed methods approach, using a survey and in-depth interviews, was adopted. The survey covered 8 concepts: prioritization/identification of potentially obsolete technologies; program development; implementation; mitigation; program championing; stakeholder engagement; monitoring; and reinvestment. Members of Health Technology Assessment International (HTAi) and the International Network of Agencies for Health Technology Assessment (INAHTA) formed the sampling frame. Participation was solicited via email and the survey was administered online using SurveyMonkey. Survey results were analyzed using descriptive statistics. To gather more in-depth knowledge, semi-structured interviews were conducted among organizations with active HTR programs. Interview questions were developed using the same 8 concepts. The hour-long interviews were recorded, transcribed and analyzed using constant comparative analysis.</p> <p>Results</p> <p>Ninety-five individuals responded to the survey: 49 were not discussing HTR, 21 were beginning to discuss HTR, nine were imminently developing a program, and 16 participants had programs and were completing reassessments. The survey results revealed that methods vary widely and that although HTR is a powerful tool, it is currently not being used to its full potential. Of the 16 with active programs, nine agreed to participate in follow-up interviews. Interview participants identified early and extensive stakeholder engagement as the most important factors for success. A lack of top-down support and financial and human resources are inhibiting program development.</p> <p>Discussion</p> <p>HTR is in its infancy. Although HTRs are being conducted, there are no standardized approaches. However, much can be learned from current international work. Future work should focus on developing a comprehensive methodology, reporting the processes of reassessments and sharing successes and challenges in a common platform.</p>
url http://www.health-policy-systems.com/content/10/1/38
work_keys_str_mv AT leggettlaurae currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT mackeangail currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT noseworthytomw currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT sutherlandlloyd currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT clementfiona currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
_version_ 1725919390281498624